Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 29, 2021Makara Journal of ScienceOpen Access

COVID-19 In Silico Drug with Zingiber officinale Natural Product Compound Library Targeting the Mpro Protein

View Full Paper
Ask AI
Bookmark
Share

Authors

RWRenadya Maulani WijayaIndonesia International Institute for Life SciencesMHMuhammad Aldino HafidzhahUniversity of IndonesiaVKViol Dhea KharismaUniversity of Surabaya

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wijaya et al. (2021) studied this question.

synapsesocial.com/papers/6a7c501d169fe1af7cc2b42fhttps://doi.org/10.7454/mss.v25i3.1244
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)2019 · 1,398 citations
  2. 2Improving accuracy and efficiency of blind protein‐ligand docking by focusing on predicted binding sites2008 · 135 citations
  3. 3Drug Repurposing Option for COVID-2019 with Structural Bioinformatics of Chemical Interactions Approach2020 · 15 citations